Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2022-03, Vol.45 (3), p.e70-e71
Hauptverfasser: Quinn, Lauren M, Thayakaran, Rasiah, Thomas, Neil, Nirantharakumar, Krishnarajah, Narendran, Parth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e71
container_issue 3
container_start_page e70
container_title Diabetes care
container_volume 45
creator Quinn, Lauren M
Thayakaran, Rasiah
Thomas, Neil
Nirantharakumar, Krishnarajah
Narendran, Parth
description
doi_str_mv 10.2337/dc21-2372
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8918199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2640396507</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2082-a4c50233d98ef0248db3f937bd366d7b4f782bb2e40544a002e9bca5c2b89f0c3</originalsourceid><addsrcrecordid>eNpdkc-KFDEQh4Mo7rh68AUk4MU99JhUku5EQXDHUQcGvIxem3S62snS_zbpXpin8VVNs-ugnpJQXz6q6kfIS87WIETxtnbAMxAFPCIrboTKlJL6MVkxLk2mjIEL8izGG8aYlFo_JRdCgVRC5SvyazN0HfYTHXq6t-7oe4oTte2aHo5Ir7HHxjtvW7ptGnRTpENDtza0HgP9gSHOMX2b0mPXjS0uJjv55ErYrp-wj_4OF1Ww44km-eE0IuX0k7cVThjX5xvd2IAUGPD3Ur4DAJUBCPacPGlsG_HFw3lJvn_eHjZfs_23L7vNx33mgGnIrHSKpV3URmPDQOq6Eo0RRVWLPK-LSjaFhqoClExJaRkDNJWzykGlTcOcuCQf7r3jXHVYuzRIsG05Bt_ZcCoH68t_K70_lj-Hu1IbrrkxSfDmQRCG2xnjVHY-Omxb2-MwxxJykXOZG60S-vo_9GaYQ5_GS5RkwuSKFYm6uqdcGGIM2Jyb4axcYi-X2Msl9sS--rv7M_knZ_Eb_86l3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2640396507</pqid></control><display><type>article</type><title>Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Quinn, Lauren M ; Thayakaran, Rasiah ; Thomas, Neil ; Nirantharakumar, Krishnarajah ; Narendran, Parth</creator><creatorcontrib>Quinn, Lauren M ; Thayakaran, Rasiah ; Thomas, Neil ; Nirantharakumar, Krishnarajah ; Narendran, Parth</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>ISSN: 1935-5548</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc21-2372</identifier><identifier>PMID: 35245356</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Blood Glucose ; Diabetes mellitus (insulin dependent) ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 2 ; e-Letters: Comments and Responses ; Humans</subject><ispartof>Diabetes care, 2022-03, Vol.45 (3), p.e70-e71</ispartof><rights>Copyright American Diabetes Association Mar 2022</rights><rights>2022 by the American Diabetes Association 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2082-a4c50233d98ef0248db3f937bd366d7b4f782bb2e40544a002e9bca5c2b89f0c3</cites><orcidid>0000-0003-0500-4417 ; 0000-0002-4583-8793</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35245356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quinn, Lauren M</creatorcontrib><creatorcontrib>Thayakaran, Rasiah</creatorcontrib><creatorcontrib>Thomas, Neil</creatorcontrib><creatorcontrib>Nirantharakumar, Krishnarajah</creatorcontrib><creatorcontrib>Narendran, Parth</creatorcontrib><title>Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><subject>Blood Glucose</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 2</subject><subject>e-Letters: Comments and Responses</subject><subject>Humans</subject><issn>0149-5992</issn><issn>1935-5548</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc-KFDEQh4Mo7rh68AUk4MU99JhUku5EQXDHUQcGvIxem3S62snS_zbpXpin8VVNs-ugnpJQXz6q6kfIS87WIETxtnbAMxAFPCIrboTKlJL6MVkxLk2mjIEL8izGG8aYlFo_JRdCgVRC5SvyazN0HfYTHXq6t-7oe4oTte2aHo5Ir7HHxjtvW7ptGnRTpENDtza0HgP9gSHOMX2b0mPXjS0uJjv55ErYrp-wj_4OF1Ww44km-eE0IuX0k7cVThjX5xvd2IAUGPD3Ur4DAJUBCPacPGlsG_HFw3lJvn_eHjZfs_23L7vNx33mgGnIrHSKpV3URmPDQOq6Eo0RRVWLPK-LSjaFhqoClExJaRkDNJWzykGlTcOcuCQf7r3jXHVYuzRIsG05Bt_ZcCoH68t_K70_lj-Hu1IbrrkxSfDmQRCG2xnjVHY-Omxb2-MwxxJykXOZG60S-vo_9GaYQ5_GS5RkwuSKFYm6uqdcGGIM2Jyb4axcYi-X2Msl9sS--rv7M_knZ_Eb_86l3Q</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Quinn, Lauren M</creator><creator>Thayakaran, Rasiah</creator><creator>Thomas, Neil</creator><creator>Nirantharakumar, Krishnarajah</creator><creator>Narendran, Parth</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0500-4417</orcidid><orcidid>https://orcid.org/0000-0002-4583-8793</orcidid></search><sort><creationdate>20220301</creationdate><title>Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230</title><author>Quinn, Lauren M ; Thayakaran, Rasiah ; Thomas, Neil ; Nirantharakumar, Krishnarajah ; Narendran, Parth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2082-a4c50233d98ef0248db3f937bd366d7b4f782bb2e40544a002e9bca5c2b89f0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood Glucose</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 2</topic><topic>e-Letters: Comments and Responses</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quinn, Lauren M</creatorcontrib><creatorcontrib>Thayakaran, Rasiah</creatorcontrib><creatorcontrib>Thomas, Neil</creatorcontrib><creatorcontrib>Nirantharakumar, Krishnarajah</creatorcontrib><creatorcontrib>Narendran, Parth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quinn, Lauren M</au><au>Thayakaran, Rasiah</au><au>Thomas, Neil</au><au>Nirantharakumar, Krishnarajah</au><au>Narendran, Parth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>45</volume><issue>3</issue><spage>e70</spage><epage>e71</epage><pages>e70-e71</pages><issn>0149-5992</issn><issn>1935-5548</issn><eissn>1935-5548</eissn><cop>United States</cop><pub>American Diabetes Association</pub><pmid>35245356</pmid><doi>10.2337/dc21-2372</doi><orcidid>https://orcid.org/0000-0003-0500-4417</orcidid><orcidid>https://orcid.org/0000-0002-4583-8793</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2022-03, Vol.45 (3), p.e70-e71
issn 0149-5992
1935-5548
1935-5548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8918199
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Blood Glucose
Diabetes mellitus (insulin dependent)
Diabetes Mellitus, Type 1 - drug therapy
Diabetes Mellitus, Type 2
e-Letters: Comments and Responses
Humans
title Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A52%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20Lachin%20et%20al.%20The%20Beneficial%20Effects%20of%20Earlier%20Versus%20Later%20Implementation%20of%20Intensive%20Therapy%20in%20Type%201%20Diabetes.%20Diabetes%20Care%202021;44:2225-2230&rft.jtitle=Diabetes%20care&rft.au=Quinn,%20Lauren%20M&rft.date=2022-03-01&rft.volume=45&rft.issue=3&rft.spage=e70&rft.epage=e71&rft.pages=e70-e71&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dc21-2372&rft_dat=%3Cproquest_pubme%3E2640396507%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2640396507&rft_id=info:pmid/35245356&rfr_iscdi=true